Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04985097
Other study ID # CASVENM-20-437
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2018
Est. completion date July 20, 2021

Study information

Verified date July 2021
Source Increase-Tech
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This multicentre randomised controlled trial aimed to reduce the visual discomfort that patients implanted with trifocal diffractive intraocular lenses may experience after surgery. To this end, a visual training software (Optictrain) was developed in which Gabor patches were presented to the patient on a hand-held electronic device. Patients who met all inclusion criteria and consented to participate underwent half an hour of visual training per day for a period of 20 consecutive days remotely on a colourimetrically characterised Samsung Galaxy Tab A device on which the Optictrain software (n=30) or a placebo software (n=30), respectively, was pre-installed. Corrected and uncorrected near, intermediate and distance visual acuity (VA) and mesopic near and distance contrast sensitivity (CS) were measured monocularly and binocularly at two visits: during the first postoperative week (V0) and after 20 days of visual training with the assigned software (V1). The statistical analysis of the results obtained in the study has not yet been carried out.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date July 20, 2021
Est. primary completion date June 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Age between 18 an 90 years - Patients implanted with trifocal diffractive intraocular lenses - Availability and motivation to perform the visual training assigned Exclusion Criteria: - Age under 18 or over 90 years - Presence of irregular cornea, illiteracy or cognitive impairment - History of eye surgery or presence of any active ocular disease - Intraoperative complications leading to significant visual sequelae - Patients implanted with monofocal, extended depth of focus or refractive multifocal IOLs

Study Design


Related Conditions & MeSH terms

  • Blindness
  • Visual Acuity Reduced Transiently
  • Visual Disturbances and Blindness

Intervention

Procedure:
Implantation of trifocal diffractive intraocular lenses
Postsurgical monocular and binocular assessment of corrected and uncorrected near, intermediate and distance visual acuity and near and distance mesopic contrast sensitivity before and after the assigned vision training

Locations

Country Name City State
Spain Faculty of Medicine, University of Valladolid Valladolid

Sponsors (4)

Lead Sponsor Collaborator
Increase-Tech Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA, Ministerio de Economía y Competitividad, Spain, University of Alicante

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual acuity Monocular and binocular corrected and uncorrected visual acuity under near, intermediate and distance conditions During the first post-operative week and after 20 days of vision training with the randomly assigned software
Primary Contrast sensitivity Monocular and binocular mesopic contrast sensitivity under near and distance conditions During the first post-operative week and after 20 days of vision training with the randomly assigned software
See also
  Status Clinical Trial Phase
Completed NCT04703231 - Comparison of Ocular Findings in Patients Between Surgical and Natural Menopause
Completed NCT04724525 - Changes in Power and Cylinder Axis of Toric Soft Contact Lenses (LKL) N/A
Completed NCT01244334 - Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery. Phase 4
Terminated NCT03409185 - The Incidence of Glistenings in the 2017 Intraocular Lenses Made by Alcon and Abbott Medical Optics N/A
Terminated NCT02665689 - Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab Phase 4